Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 4:22 PM View:  | Cara Therapeutics, Inc. (CARA) | 05-Apr-24 | Sale (Planned) | 2,753 | $0.83 | $2,284.99 | (5%) 56.12K to 53.37K | |
| 04-Mar-24 4:13 PM View: | Cara Therapeutics, Inc. (CARA) | 29-Feb-24 | Sale (Planned) | 3,293 | $0.89 | $2,930.77 | (6%) 59.41K to 56.12K | |
| 05-Feb-24 4:30 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Feb-24 | Grant | 13,500 | -- | -- | 25% 53.68K to 67.18K | |
| 27-Jun-23 4:07 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Jun-23 | Sale (Planned) | 2,723 | $3.51 | $9,557.73 | (5%) 56.4K to 53.68K | |
| 06-Apr-23 5:13 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Apr-23 | Sale (Planned) | 2,481 | $4.91 | $12,181.70 | (4%) 58.88K to 56.4K | |
| 07-Mar-23 4:43 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-23 | Sale (Planned) | 6,221 | $9.71 | $60,405.90 | (10%) 65.11K to 58.88K | |
| 17-Feb-23 4:27 PM View: | Cara Therapeutics, Inc. (CARA) | 16-Feb-23 | Sale (Planned) | 2,265 | $10.20 | $23,103.00 | (3%) 67.37K to 65.11K | |
| 12-Feb-24 5:13 PM View: | Cara Therapeutics, Inc. (CARA) | 08-Feb-23 | Sale (Planned) | 7,770 | $0.53 | $4,118.10 | (12%) 67.18K to 59.41K | |
| 19-Jan-23 4:18 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Jan-23 | Market Sale (Planned) | 2,265 | $10.81 | $24,484.70 | (3%) 69.64K to 67.37K | (12%) |
| 03-Jan-23 4:32 PM View: | Cara Therapeutics, Inc. (CARA) | 29-Dec-22 | Sale (Planned) | 2,265 | $10.18 | $23,057.70 | (3%) 71.9K to 69.64K | |
| 23-Dec-22 4:53 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Dec-22 | Market Sale (Planned) | 2,992 | $11.27 | $33,719.80 | (4%) 74.89K to 71.9K | (8%) |
| 05-Apr-22 5:50 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Apr-22 | Market Sale (Planned) | 1,642 | $11.91 | $19,556.20 | (2%) 76.53K to 74.89K | (2%) |
| 01-Mar-22 10:00 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Grant | 20,000 | -- | -- | 34% 58.51K to 78.51K | |
| 01-Mar-22 10:00 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Sale (Planned) | 1,972 | $10.29 | $20,291.90 | (3%) 78.51K to 76.53K | |
| 21-Dec-21 5:29 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Dec-21 | Grant | 12,607 | -- | -- | 27% 45.9K to 58.51K | |
| 03-Nov-21 4:55 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Nov-21 | Market Sale (Planned) | 1,000 | $17.15 | $17,150.00 | (2%) 46.9K to 45.9K | (2%) |
| 28-Oct-21 6:34 PM View: | Cara Therapeutics, Inc. (CARA) | 27-Oct-21 | Market Sale (Planned) | 1,000 | $15.00 | $15,000.00 | (2%) 47.9K to 46.9K | (9%) |
| 01-Sep-21 6:06 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Aug-21 | Market Sale (Planned) | 2,110 | $14.20 | $29,962.00 | (4%) 50.01K to 47.9K | (11%) |
| 26-Aug-21 6:16 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Aug-21 | Grant | 6,400 | -- | -- | 15% 43.61K to 50.01K | |
| 23-Apr-21 5:05 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Apr-21 | Market Sale (Planned) | 3,000 | $27.63 | $82,890.00 | (6%) 46.61K to 43.61K | 2% |
| 01-Apr-21 7:48 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Mar-21 | Grant | 16,000 | -- | -- | 52% 30.61K to 46.61K | |
| 24-Mar-21 5:55 PM View: | Cara Therapeutics, Inc. (CARA) | 22-Mar-21 | Market Sale (Planned) | 3,000 | $19.65 | $58,950.00 | (9%) 33.61K to 30.61K | (1%) |
| 08-Mar-21 5:45 PM View: | Cara Therapeutics, Inc. (CARA) | 05-Mar-21 | Market Sale (Planned) | 3,093 | $17.98 | $55,612.10 | (8%) 36.7K to 33.61K | |
| 08-Mar-21 5:45 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Mar-21 | Grant | 10,000 | -- | -- | 37% 26.7K to 36.7K | |
| 25-Feb-21 9:04 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-21 | Market Sale (Planned) | 3,372 | $19.33 | $65,180.80 | (11%) 30.07K to 26.7K | |
| 25-Feb-21 9:04 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Feb-21 | Grant | 4,000 | -- | -- | 15% 26.07K to 30.07K | |
| 24-Feb-21 5:02 PM View: | Cara Therapeutics, Inc. (CARA) | 22-Feb-21 | Market Sale (Planned) | 2,000 | $19.73 | $39,460.00 | (7%) 28.07K to 26.07K | < 1% |
| 25-Jan-21 5:32 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Jan-21 | Market Sale (Planned) | 2,000 | $20.12 | $40,240.00 | (7%) 30.07K to 28.07K | 5% |
| 30-Dec-20 6:14 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Dec-20 | Market Sale (Planned) | 1,298 | $15.30 | $19,859.40 | (4%) 31.37K to 30.07K | (< 1%) |
| 29-Dec-20 6:43 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Dec-20 | Grant | 4,000 | -- | -- | 15% 27.37K to 31.37K | |
| 23-Dec-20 7:11 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Dec-20 | Market Sale (Planned) | 2,000 | $15.00 | $30,000.00 | (7%) 29.37K to 27.37K | (5%) |
| 25-Nov-20 4:48 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Nov-20 | Market Sale (Planned) | 2,000 | $15.31 | $30,620.00 | (6%) 31.37K to 29.37K | (3%) |
| 13-Nov-20 5:39 PM View: | Cara Therapeutics, Inc. (CARA) | 10-Nov-20 | Market Sale (Planned) | 2,000 | $15.00 | $30,000.00 | (6%) 33.37K to 31.37K | (5%) |
| 22-Oct-20 6:00 PM View: | Cara Therapeutics, Inc. (CARA) | 20-Oct-20 | Market Sale (Planned) | 2,000 | $15.00 | $30,000.00 | (6%) 35.37K to 33.37K | (5%) |
| 12-Jun-20 6:00 PM View: | Cara Therapeutics, Inc. (CARA) | 12-Jun-20 | Market Sale (Planned) | 10,627 | $15.20 | $161,530.00 | (23%) 46.0K to 35.37K | (3%) |
| 12-Jun-20 6:00 PM View: | Cara Therapeutics, Inc. (CARA) | 10-Jun-20 | Grant | 30,000 | -- | -- | 188% 16.0K to 46.0K | |
| 26-Feb-20 5:09 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Feb-20 | Grant | 16,000 | -- | -- | 100% 0 to 16.0K |